SPAG8
Basic information
Region (hg38): 9:35808045-35812272
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome (3 variants)
- Acromesomelic dysplasia 1, Maroteaux type (2 variants)
- Tall stature-scoliosis-macrodactyly of the great toes syndrome;Acromesomelic dysplasia 1, Maroteaux type (1 variants)
- Epilepsy, familial focal, with variable foci 2 (1 variants)
- NPR2-related disorder (1 variants)
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPAG8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 56 | 61 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 35 | 18 | 69 | |||
Total | 6 | 7 | 93 | 21 | 11 |
Highest pathogenic variant AF is 0.00000657
Variants in SPAG8
This is a list of pathogenic ClinVar variants found in the SPAG8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
9-35808216-A-G | not specified | Uncertain significance (Oct 28, 2024) | ||
9-35808237-T-C | not specified | Uncertain significance (Dec 06, 2022) | ||
9-35808262-G-A | not specified | Uncertain significance (Mar 18, 2024) | ||
9-35808266-T-A | not specified | Uncertain significance (Jul 30, 2024) | ||
9-35808277-C-T | Benign (Jun 14, 2018) | |||
9-35808294-T-C | not specified | Uncertain significance (Oct 25, 2023) | ||
9-35808337-C-G | Benign (Nov 12, 2018) | |||
9-35808498-C-T | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Likely benign (Oct 18, 2024) | ||
9-35808507-A-T | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Likely pathogenic (Nov 02, 2021) | ||
9-35808509-G-T | Acromesomelic dysplasia 1, Maroteaux type | Uncertain significance (Jan 01, 2019) | ||
9-35808516-C-T | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome • Acromesomelic dysplasia 1, Maroteaux type • Short stature with nonspecific skeletal abnormalities | Pathogenic/Likely pathogenic (Sep 01, 2022) | ||
9-35808517-G-A | Acromesomelic dysplasia 1, Maroteaux type • Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Conflicting classifications of pathogenicity (Jul 01, 2024) | ||
9-35808519-T-C | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Uncertain significance (Oct 29, 2024) | ||
9-35808527-G-A | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Uncertain significance (Apr 18, 2024) | ||
9-35808528-C-A | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Uncertain significance (Apr 10, 2022) | ||
9-35808533-A-AT | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Pathogenic (Feb 14, 2023) | ||
9-35808534-T-C | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Uncertain significance (Aug 31, 2021) | ||
9-35808535-G-A | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Uncertain significance (Apr 23, 2024) | ||
9-35808547-C-A | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Likely benign (Oct 30, 2023) | ||
9-35808550-C-A | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Likely benign (Dec 20, 2023) | ||
9-35808552-C-T | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Uncertain significance (Jan 19, 2022) | ||
9-35808557-C-T | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome • NPR2-related disorder | Pathogenic (Dec 17, 2024) | ||
9-35808558-G-A | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Uncertain significance (Jan 21, 2025) | ||
9-35808560-A-C | Acromesomelic dysplasia 1, Maroteaux type;Tall stature-scoliosis-macrodactyly of the great toes syndrome | Uncertain significance (Oct 02, 2024) | ||
9-35808569-C-T | Tall stature-scoliosis-macrodactyly of the great toes syndrome;Acromesomelic dysplasia 1, Maroteaux type | Uncertain significance (Aug 23, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SPAG8 | protein_coding | protein_coding | ENST00000340291 | 8 | 4228 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.68e-12 | 0.108 | 122844 | 77 | 2827 | 125748 | 0.0116 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.568 | 253 | 280 | 0.905 | 0.0000145 | 3211 |
Missense in Polyphen | 39 | 56.01 | 0.69631 | 686 | ||
Synonymous | 0.128 | 106 | 108 | 0.984 | 0.00000583 | 1054 |
Loss of Function | 0.617 | 20 | 23.2 | 0.862 | 0.00000126 | 235 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0197 | 0.0198 |
Ashkenazi Jewish | 0.000497 | 0.000496 |
East Asian | 0.0792 | 0.0788 |
Finnish | 0.0430 | 0.0362 |
European (Non-Finnish) | 0.00202 | 0.00201 |
Middle Eastern | 0.0792 | 0.0788 |
South Asian | 0.00183 | 0.00183 |
Other | 0.00606 | 0.00588 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in spermatogenesis by enhancing the binding of CREM isoform tau to its coactivator FHL5 and increasing the FHL5-regulated transcriptional activation of CREM isoform tau (By similarity). Involved in the acrosome reaction and in binding of sperm to the zona pellucida (By similarity). Plays a role in regulation of the cell cycle by controlling progression through the G2/M phase, possibly by delaying the activation of CDK1 which is required for entry into mitosis (PubMed:19548270). May play a role in fertility and microtubule formation through interaction with RANBP9 (PubMed:10500252). {ECO:0000250|UniProtKB:Q3V0Q6, ECO:0000269|PubMed:10500252, ECO:0000269|PubMed:19548270}.;
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.927
- rvis_EVS
- 0.87
- rvis_percentile_EVS
- 88.82
Haploinsufficiency Scores
- pHI
- 0.118
- hipred
- N
- hipred_score
- 0.123
- ghis
- 0.427
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.265
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Spag8
- Phenotype
Gene ontology
- Biological process
- cell cycle;spermatogenesis;single fertilization;biological_process;cell differentiation;positive regulation of transcription by RNA polymerase II
- Cellular component
- acrosomal vesicle;nucleus;cytoplasm;spindle;membrane
- Molecular function
- molecular_function;protein binding;microtubule binding